Table 2.
TAC3 pathway based on gene-gene expression correlations at 108 SCZ risk loci
| Gene | Isoform | TAC3 (ρ) | # COR | Locus | SNP |
|---|---|---|---|---|---|
| CA14 | 219464_at | 0.876 | 39 | chr1:149998890–150242490 | rs140505938 |
| OTUD7B | 1555139_a_at | 0.778 | 21 | chr1:149998890–150242490 | rs140505938 |
| 229488_at | 0.69 | ||||
| EFHD1 | 209343_at | 0.863 | 42 | chr2:233559301–233753501 | rs6704768 |
| PCGEM1 | 234515_at | 0.763 | 25 | chr2:193848340–194028340 | rs59979824 |
| BOLL | 236954_at | 0.692 | 18 | chr2:198148577–198835577 | rs6434928 |
| NT5DC2 [33] | 1556895_a_at | 0.752 | 25 | chr3:52541105–52903405 | rs2535627 |
| C3orf49 | 1553805_at | 0.69 | 5 | chr3:63792650–64004050 | rs832187 |
| FXR1* [33] | 1569171_a_at | 0.683 | 7 | chr3:180588843–181205585 | rs9841616 |
| NISCH | 201591_s_at | −0.753 | 15 | chr3:52541105–52903405 | rs2535627 |
| GPM6A [33] | 236024_at | 0.757 | 27 | chr4:176851001–176875801 | rs1106568 |
| NEK1 [33] | 216213_at | 0.689 | 5 | chr4:170357552–170646052 | rs10520163 |
| NDUFA2 | 222971_at | 0.734 | 12 | chr5:140023664–140222664 | chr5_140143664_I |
| GFRA3 [33] | 214479_at | 0.708 | 12 | chr5:137598121–137948092 | rs3849046 |
| HCG22 | 1560767_at | 0.87 | 40 | chr6:28303247–28712247 | rs115329265 |
| HFE | 210864_x_at | 0.847 | 38 | chr6:28303247–28712247 | rs115329265 |
| 211863_x_at | 0.778 | ||||
| 206086_x_at | 0.75 | ||||
| 211866_x_at | 0.736 | ||||
| 211332_x_at | 0.692 | ||||
| EHMT2 | 229079_at | 0.803 | 30 | chr6:28303247–28712247 | rs115329265 |
| PFDN6 | 242048_at | 0.758 | 21 | chr6:28303247–28712247 | rs115329265 |
| 222019_at | 0.755 | ||||
| HLADOA | 217001_x_at | 0.717 | 13 | chr6:28303247–28712247 | rs115329265 |
| PTN* | 208408_at | 0.841 | 41 | chr7:137039644–137085244 | rs3735025 |
| 209466_x_at | 0.792 | ||||
| MPP6 [33] | 205429_s_at | −0.69 | 11 | chr7:24619494–24832094 | chr7_24747494_D |
| TSNARE1 | 1552799_at | 0.778 | 19 | chr8:143309503–143330533 | rs4129585 |
| TLE1* | 203220_s_at | 0.738 | 27 | chr9:84630941–84813641 | rs11139497 |
| CYP17A1 | 205502_at | 0.778 | 25 | chr10:104423800–105165583 | rs55833108 |
| CNNM2 [33] | 1554523_a_at | 0.7 | 7 | chr10:104423800–105165583 | rs55833108 |
| CHRM4 | 221357_at | 0.851 | 36 | chr11:46342943–46751213 | chr11_46350213_D |
| LUZP2 | 215323_at | 0.826 | 37 | chr11:24367320–24412990 | rs11027857 |
| ARHGAP1 | 216689_x_at | 0.783 | 37 | chr11:46342943–46751213 | chr11_46350213_D |
| CREB3L1 | 213059_at | 0.78 | 23 | chr11:46342943–46751213 | chr11_46350213_D |
| CLP1 | 1566151_at | 0.778 | 33 | chr11:57386294–57682294 | rs9420 |
| CTNND1 [33] | 1557944_s_at | 0.757 | 35 | chr11:57386294–57682294 | rs9420 |
| DRD2 * | 206590_x_at | 0.754 | 12 | chr11:113317794–113423994 | rs2514218 |
| DGKZ | 239342_at | 0.682 | 8 | chr11:46342943–46751213 | chr11_46350213_D |
| PITPNM2 | 1552923_a_at | 0.736 | 23 | chr12:123448113–123909113 | rs2851447 |
| TMTC1 | 224397_s_at | 0.699 | 4 | chr12:29905265–29940365 | rs679087 |
| MPHOSPH9 [33] | 221965_at | −0.781 | 20 | chr12:123448113–123909113 | rs2851447 |
| RGS6 [31] | 214538_x_at | 0.684 | 8 | chr14:72417326–72450526 | rs2332700 |
| KLC1 | 212878_s_at | −0.782 | 26 | chr14:103996234–104184834 | rs12887734 |
| CHRNA3* | 210221_at | 0.834 | 44 | chr15:78803032–78926732 | rs8042374 |
| 211587_x_at | 0.829 | ||||
| GRIN2A* [31] | 206534_at | 0.768 | 28 | chr16:9875519–9970219 | rs9922678 |
| ASPHD1 | 1553997_a_at | 0.761 | 23 | chr16:29924377–30144877 | rs12691307 |
| ERCC4 | 210158_at | 0.692 | 5 | chr16:13728459–13761359 | rs7405404 |
| NFATC3 [33] | 225139_at | −0.73 | 40 | chr16:67709340–68311340 | rs8044995 |
| 210555_s_at | −0.785 | ||||
| 207416_s_at | −0.825 | ||||
| MYO15A | 220288_at | 0.774 | 30 | chr17:17722402–18030202 | rs8082590 |
| TOM1L2 | 214840_at | 0.682 | 2 | chr17:17722402–18030202 | rs8082590 |
| CILP2 | 1552289_a_at | 0.812 | 31 | chr19:19374022–19658022 | rs2905426 |
| HAPLN4 | 235420_at | 0.77 | 35 | chr19:19374022–19658022 | rs2905426 |
| TM6SF2 | 234092_s_at | 0.759 | 22 | chr19:19374022–19658022 | rs2905426 |
| GATAD2A [33] | 222526_at | −0.693 | 13 | chr19:19374022–19658022 | rs2905426 |
| SUGP1 | 215004_s_at | −0.701 | 12 | chr19:19374022–19658022 | rs2905426 |
| KCNB1* [31] | 231053_at | 0.788 | 13 | chr20:48114136–48131649 | rs7267348 |
| PTGIS [33] | 208131_s_at | 0.763 | 6 | chr20:48114136–48131649 | rs7267348 |
| SEPT3 | 223362_s_at | 0.839 | 26 | chr22:42315744–42689414 | rs6002655 |
| TCF20 | 215511_at | 0.839 | 39 | chr22:42315744–42689414 | rs6002655 |
| 238667_at | 0.803 | ||||
| TNFRSF13C | 1552892_at | 0.826 | 37 | chr22:42315744–42689414 | rs6002655 |
| CYP2D6 | 215809_at | 0.706 | 6 | chr22:42315744–42689414 | rs6002655 |
From top 10% of significant correlations (ρ ≥│0.682│). chr=chromosome.
TAC3 isoform (219992_at) correlations between genes. ρ =correlations; # other genes= the number of correlations with other genes; Bold= four genes implicated in the DRD2 pathway
= seven known genes implicated in SCZ etiology or treatment before the 2014 GWAS study came out; Italics=12 genes cited in the literature that reference the 2014 GWAS study.[5]